<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412017000100009</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Nuevas perspectivas de la citología en diagnóstico molecular del cáncer epitelial de ovario y endometrio]]></article-title>
<article-title xml:lang="en"><![CDATA[New perspectives of cytology in molecular diagnosis of ovarian and endometrial epithelial cancer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barquet-Muñoz]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cantú de León]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Porquillo-Cortés]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Departamento de Ginecología oncológica Departamento de Ginecología oncológica ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,aff2  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Nacional de Cancerología Servicio Social en Investigación ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>01</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>01</month>
<year>2017</year>
</pub-date>
<volume>85</volume>
<numero>1</numero>
<fpage>47</fpage>
<lpage>54</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412017000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412017000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412017000100009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO:  describir la bibliografía donde se identificaron biomarcadores moleculares en muestras de citología cervical en base líquida para detectar cáncer epitelial de endometrio y ovario.  METODOLOGÍA:  búsqueda electrónica en las principales bases de datos de artículos relacionados con la detección de cáncer de ovario y de endometrio con los siguientes términos: citología en base líquida, cáncer epitelial de ovario, cáncer epitelial de endometrio, biomarcadores moleculares.  RESULTADOS:  los cánceres epitelial de ovario y de endometrio son enfermedades que carecen de un método de tamizaje eficaz. La citología en base líquida ofrece una manera eficaz de detectar alteraciones celulares y moleculares. Mediante la asociación entre la citología en base líquida y los métodos moleculares en el aparato genital inferior es posible identificar biomarcadores específicos; esto abre la posibilidad de desarrollar métodos de tamizaje para cáncer epitelial de endometrio y ovario.  CONCLUSIONES:  mediante el uso de la citología en base líquida es posible detectar cáncer epitelial de endometrio y ovario.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE:  To describe the literature that has identified molecular biomarkers in liquid-based cervical cytology samples to detect endometrial and ovary epithelial cancer.  METHODOLOGY:  An electronic search was conducted in the main databases in articles related to the detection of ovarian and endometrial cancer with the following search terms: liquid-based cytology, ovarian epithelial cancer, endometrial epithelial cáncer, molecular biomarkers.  RESULTS:  Epithelial ovarian and endometrial cancer are diseases that lack an effective screening method. Liquid-based cytology provides an effective way to detect cellular and molecular alterations in the detection of these neoplasms. Through the association between liquid-based cytology and molecular methods it is possible to identify specific biomarkers in the lower genital tract, opening up the possibility of developing screening methods for endometrial and ovary epithelial cancer.  CONCLUSIONS:  It is possible the detection of endometrial cancer and, to a lesser extent of epithelial ovarian cancer by using liquid-based Pap test.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[citología en base líquida]]></kwd>
<kwd lng="es"><![CDATA[cáncer de ovario]]></kwd>
<kwd lng="es"><![CDATA[cáncer de endometrio]]></kwd>
<kwd lng="es"><![CDATA[biomarcadores moleculares]]></kwd>
<kwd lng="en"><![CDATA[Liquid-based cervical cytology]]></kwd>
<kwd lng="en"><![CDATA[Ovarian cancer]]></kwd>
<kwd lng="en"><![CDATA[Molecular biomarkers]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tamizaje en cáncer cervical: Conocimiento de la utilidad y uso de citología cervical en México]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguilar-Pérez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Leyva-López]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Angulo-Nájera]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Salinas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lazcano-Ponce]]></surname>
<given-names><![CDATA[EC.]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev. Saude Publica]]></source>
<year>2003</year>
<volume>37</volume>
<page-range>100-6</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Early detection of ovarian cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Badgwell]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bast]]></surname>
<given-names><![CDATA[RC.]]></given-names>
</name>
</person-group>
<source><![CDATA[Dis. Markers]]></source>
<year>2007</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kinde]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Sci. Transl. Med.]]></source>
<year>2013</year>
<volume>5</volume>
<page-range>167ra4</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bakkum-Gamez]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
</person-group>
<source><![CDATA[Gynecol. Oncol.]]></source>
<year>2014</year>
<volume>137</volume>
<page-range>14-22</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The biology of ovarian cancer: new opportunities for translation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bast]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Hennessy]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mills]]></surname>
<given-names><![CDATA[GB.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat. Rev. Cancer]]></source>
<year>2009</year>
<volume>9</volume>
<page-range>415-28</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Integrated genomic analyses of ovarian carcinoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cancer]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Atlas]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature]]></source>
<year>2011</year>
<volume>474</volume>
<page-range>609-15</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurman]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shih]]></surname>
<given-names><![CDATA[IM.]]></given-names>
</name>
</person-group>
<source><![CDATA[Hum Pathol]]></source>
<year>2011</year>
<volume>42</volume>
<page-range>918-31</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Metastatic patterns at autopsy in patients with ovarian carcinoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guth]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer]]></source>
<year>2007</year>
<volume>110</volume>
<page-range>1272-80</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: Evidence of distinct molecular genetic pathways]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lax]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Kendall]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Tashiro]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Slebos]]></surname>
<given-names><![CDATA[RJC]]></given-names>
</name>
<name>
<surname><![CDATA[Ellenson]]></surname>
<given-names><![CDATA[LH.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer]]></source>
<year>2000</year>
<volume>88</volume>
<page-range>814-24</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mutational Analysis of the PTEN Gene in Endometrial Carcinoma and Hyperplasia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Am. J. Clin. Pathol.]]></source>
<year>2001</year>
<volume>115</volume>
<page-range>32-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Abnormalities of the APC/beta-catenin pathway in endometrial cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreno-Bueno]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncogene]]></source>
<year>2002</year>
<volume>21</volume>
<page-range>7981-90</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oda]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Stokoe]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Taketani]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[McCormick]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Res]]></source>
<year>2005</year>
<volume>65</volume>
<page-range>10669-73</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[LWT]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Discov]]></source>
<year>2011</year>
<volume>1</volume>
<page-range>170-85</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Genome Res.]]></source>
<year>2012</year>
<volume>22</volume>
<page-range>2120-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuhn]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Natl. Cancer Inst.]]></source>
<year>2012</year>
<volume>104</volume>
<page-range>1503-13</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kinde]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Sci Transl Med]]></source>
<year>2013</year>
<volume>5</volume>
<page-range>167ra4</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Methylated DNA collected by tampons--a new tool to detect endometrial cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fiegl]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Epidemiol. Biomarkers Prev]]></source>
<year>2004</year>
<volume>13</volume>
<page-range>882-8</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suehiro]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin. Cancer Res.]]></source>
<year>2008</year>
<volume>14</volume>
<page-range>3354-61</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guida]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur. J. Gynaecol. Oncol.]]></source>
<year>2009</year>
<volume>30</volume>
<page-range>267-70</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[YW]]></given-names>
</name>
</person-group>
<source><![CDATA[Gynecol. Oncol.]]></source>
<year>2010</year>
<volume>117</volume>
<page-range>239-47</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[DNA methylation in endometrial cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tao]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Freudenheim]]></surname>
<given-names><![CDATA[JL.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epigenetics]]></source>
<year>2010</year>
<volume>5</volume>
<page-range>491-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Identification of candidate epigenetic biomarkers for ovarian cancer detection]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[YW]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncol. Rep.]]></source>
<year>2009</year>
<volume>22</volume>
<page-range>853-61</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Genome-scale screen for DNA methylation-based detection markers for ovarian cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2011</year>
<volume>6</volume>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: A proof of principle study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Widschwendter]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Int. J. Cancer]]></source>
<year>2009</year>
<volume>125</volume>
<page-range>2214-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chin]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Bristow]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Korst]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Walts]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lagasse]]></surname>
<given-names><![CDATA[LD.]]></given-names>
</name>
</person-group>
<source><![CDATA[American Journal of Obstetrics and Gynecology]]></source>
<year>2000</year>
<volume>182</volume>
<page-range>1278-82</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cancer genes and the pathways they control]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vogelstein]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kinzler]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
<name>
<surname><![CDATA[Vogelstein]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kinzler]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Med]]></source>
<year>2004</year>
<volume>10</volume>
<page-range>789-99</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comparison of Liquid-Based Cytology With Conventional Cytology for Detection: A Randomized Controlled Trial]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siebers]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA]]></source>
<year>2009</year>
<volume>302</volume>
<page-range>1757-65</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bristow]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Tomacruz]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Armstrong]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[Trimble]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Montz]]></surname>
<given-names><![CDATA[FJ.]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Clin. Oncol.]]></source>
<year>2002</year>
<volume>20</volume>
<page-range>1248-59</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[COSMIC: Mining complete cancer genomes in the catalogue of somatic mutations in cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Forbes]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<source><![CDATA[Nucleic Acids Res.]]></source>
<year>2011</year>
<volume>39</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
